UAE-headquartered global healthcare service provider EarlyHealth Group has taken a major step in its international expansion by acquiring Corena Ecza Deposu, one of Türkiye's leading pharmaceutical distribution companies. The deal is a cornerstone of EarlyHealth's USD 100 million investment strategy aimed at enhancing its presence in emerging markets.
Having entered the Turkish market in 2023, EarlyHealth's acquisition strengthens its position as a key player in the country's life sciences sector. Known for its work in clinical research and managed access programs, the company views Türkiye as a vital link in its global network. EarlyHealth CEO Dr. Dan A. Renout stated that by combining Corena's local expertise with EarlyHealth's international infrastructure, they intend to accelerate Türkiye's export capacity and expand R&D-driven academic collaborations.
Corena Founder Nihal Aygün expressed her excitement about elevating their nearly two-decade-long collaboration into a strategic partnership. She emphasized that the acquisition would support Türkiye's efforts to reduce its dependency on pharmaceutical imports while positioning the country as a vital player in the global supply chain.
The acquisition ceremony took place in Dubai, with notable attendees including Türkiye's Consul General in Dubai, Onur Saylan; Sheikh Khalifa bin Khalid Al Hamed of the Abu Dhabi Royal Family; and Investment and Finance Office Country Advisor Ahmed Emre Büyükkılıç.
Founded in California in 1984, EarlyHealth Group has expanded through strategic acquisitions across Europe and Asia. In 2023, the company relocated its headquarters to the UAE and officially entered the Turkish market by establishing an office in Istanbul and a logistics center in Ankara.
Meanwhile, Ankara-based Corena, established in 1998, already operates in Switzerland, Malta, and the UAE. This strategic acquisition marks a pivotal step in integrating Türkiye more deeply into the global life sciences and healthcare landscape.